{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:04:14Z","timestamp":1792119854245,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004722","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000}}],"reference-count":33,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004722.pub2","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T14:08:51Z","timestamp":1097762931000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Transdermal nicotine for induction of remission in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Jerry","family":"McGrath","sequence":"first","affiliation":[{"name":"Health Sciences Centre; St. John's Newfoundland Canada A1B 3V6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John WD","family":"McDonald","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London Ontario Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Robarts Research Institute; Robarts Clinical Trials; P.O. Box 5015 100 Perth Drive London Ontario Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD004722.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00042737-199806000-00014","article-title":"Outcome of ulcerative colitis after treatment with transdermal nicotine","volume":"10","author":"Guslandi","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"10.1002\/14651858.CD004722.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-127-6-199709150-00020","article-title":"Transdermal nicotine for ulcerative colitis","volume":"127","author":"Guslandi","year":"1997","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1002\/14651858.CD004722.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1155\/2002\/307218","article-title":"Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine","volume":"16","author":"Guslandi","year":"2002","journal-title":"Can J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD004722.pub2-BIB0006|cit4","first-page":"85","article-title":"Colonic mucus, smoking and ulcerative colitis","volume":"78","author":"Pullan","year":"1996","journal-title":"Ann R Coll Surg Engl"},{"issue":"4 Part 2","key":"10.1002\/14651858.CD004722.pub2-BIB0004|cit5","first-page":"A765","article-title":"Transdermal nicotine treatment for ulcerative colitis: a controlled trial","volume":"104","author":"Pullan","year":"1993","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1002\/14651858.CD004722.pub2-BIB0005|cit6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1002\/14651858.CD004722.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00054725-199908000-00005","article-title":"Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis","volume":"5","author":"Louvet","year":"1999","journal-title":"Inflamm Bowel Dis"},{"issue":"5 Part 2","key":"10.1002\/14651858.CD004722.pub2-BIB0008|cit8","first-page":"Abstract","article-title":"A randomized, double-blind, placebo-controlled trial of transdermal nicotine for mildly to moderately active ulcerative colitis","volume":"110","author":"Sandborn","year":"1996","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD004722.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-126-5-199703010-00004","article-title":"Transdermal nicotine for mildly to moderately active ulcerative colitis","volume":"126","author":"Sandborn","year":"1997","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1002\/14651858.CD004722.pub2-BIB0010|cit10","first-page":"769","article-title":"Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis","volume":"8","author":"Thomas","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1002\/14651858.CD004722.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.dld.2005.05.010","article-title":"Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial","volume":"37","author":"Ingram","year":"2005","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1002\/14651858.CD004722.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(05)00849-9","article-title":"A randomized trial of nicotine enemas for active ulcerative colitis","volume":"3","author":"Ingram","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"959","key":"10.1002\/14651858.CD004722.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/pgmj.2004.031690","article-title":"Comparative study of enema retention and preference in ulcerative colitis","volume":"81","author":"Ingram","year":"2005","journal-title":"Postgrad Med J"},{"issue":"7","key":"10.1002\/14651858.CD004722.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF01536795","article-title":"Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials","volume":"35","author":"Lashner","year":"1990","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1002\/14651858.CD004722.pub2-BIB0015|cit15","first-page":"392","article-title":"Is transdermal nicotine associated with cardiovascular risk?","volume":"29","author":"Thomas","year":"1995","journal-title":"J R Coll Physicians Lond"},{"issue":"15","key":"10.1002\/14651858.CD004722.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199504133321503","article-title":"Transdermal nicotine as maintenance therapy for ulcerative colitis","volume":"332","author":"Thomas","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1002\/14651858.CD004722.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJM198703193161202","article-title":"Risk of ulcerative colitis among former and current cigarette smokers","volume":"316","author":"Boyko","year":"1987","journal-title":"N Engl J Med"},{"issue":"6330","key":"10.1002\/14651858.CD004722.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/bmj.284.6330.1706","article-title":"Non-smoking: a feature of ulcerative colitis","volume":"284","author":"Castella","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6317","key":"10.1002\/14651858.CD004722.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/bmj.284.6317.706","article-title":"Non-smoking: a feature of ulcerative colitis","volume":"284","author":"Harries","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6844","key":"10.1002\/14651858.CD004722.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","article-title":"Randomised controlled trial of azathioprine withdrawal in ulcerative colitis","volume":"305","author":"Hawthorne","year":"1992","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD004722.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJM198302033080507","article-title":"Cigarette smoking and ulcerative colitis","volume":"308","author":"Jick","year":"1983","journal-title":"N Engl J Med"},{"issue":"6325","key":"10.1002\/14651858.CD004722.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/bmj.284.6325.1291","article-title":"Controlled trial of azathioprine in chronic ulcerative colitis","volume":"284","author":"Kirk","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1002\/14651858.CD004722.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1995.tb00384.x","article-title":"Rectal aminosalicylate therapy for distal ulcerative colitis: a meta-analysis","volume":"9","author":"Marshall","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1002\/14651858.CD004722.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.40.6.775","article-title":"Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis","volume":"40","author":"Marshall","year":"1997","journal-title":"Gut"},{"issue":"7","key":"10.1002\/14651858.CD004722.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/j.1572-0241.2000.02180.x","article-title":"Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis","volume":"95","author":"Marshall","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD004722.pub2-BIB0026|cit26","volume-title":"Evidence based gastroenterology and hepatology","author":"McDonald","year":"1999"},{"issue":"2","key":"10.1002\/14651858.CD004722.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000199478","article-title":"Time relationships between cessation of smoking and onset of ulcerative colitis","volume":"37","author":"Motley","year":"1987","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD004722.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01648362","article-title":"Late presentation of ulcerative colitis in ex-smokers","volume":"3","author":"Motley","year":"1988","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1002\/14651858.CD004722.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0016-5085(19)32641-1","article-title":"A controlled trial of azathioprine in the management of chronic ulcerative colitis","volume":"69","author":"Rosenberg","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD004722.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00365528909091354","article-title":"Does smoking improve colitis?","volume":"170","author":"Rudra","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"4","key":"10.1002\/14651858.CD004722.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s005350200034","article-title":"The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis","volume":"37","author":"Sood","year":"2002","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD004722.pub2-BIB0032|cit32","first-page":"79","article-title":"Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis","volume":"22","author":"Sood","year":"2003","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD004722.pub2-BIB0033|cit33","article-title":"Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis","author":"Sutherland","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004722.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:39:00Z","timestamp":1628545140000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004722.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":33,"aliases":["10.1002\/14651858.cd004722","10.1002\/14651858.cd004722","10.1002\/14651858.cd004722"],"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004722.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,18]]}}}